Belatacept in Renal Transplantation With Intermediate Risk Maryland Aggregate Pathology Index (MAPI) Scores

NCT01496417 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

End-Stage Renal Disease

Interventions

DRUG: Belatacept

Sponsor

University of Maryland

Collaborators

[object Object]